Tag Archives: AFFY

Market Close: Big Winners & Losers for March 19, 2013 (EFUT, ATOS, PRMW, RDIB, KELYB, AFFY, MTSL, HNR, WSCI, AQQ)

By 24/7 Wall St.

stock symbol ticker

Filed under:

Here are today’s five biggest gaining stocks at closing:

eFuture Information Technology (NASDAQ: EFUT) is up 44% at $4.19.

Atossa Genetics Inc. (NASDAQ: ATOS) is up 34.1% at $12.35.

Primo Water Corp. (NASDAQ: PRMW) is up 24.8% at $1.26.

Reading International Inc. (NASDAQ: RDIB) is up 20.9% at $6.83.

Kelly Services Inc. (NASDAQ: KELYB) is up 20.2% at $19.47.

And here are today’s five biggest losing stocks at closing:

Affymax Inc. (NASDAQ: AFFY) is down 64% at $1.05.

MER Telemanagement Solutions Ltd. (NASDAQ: MTSL) is down 35.4% at $3.25.

Harvest Natural Resources Inc. (NYSE: HNR) is down 32.6% at $3.70.

WSI Industries Inc. (NASDAQ: WSCI) is down 20.9% at $5.19.

American Spectrum Realty Inc. (NYSEMKT: AQQ) is down 20% at $1.56.

Filed under: 24/7 Wall St. Wire, HI/LOW, Market Close Tagged: AFFY, AQQ, ATOS, EFUT, HNR, KELYB, MTSL, PRMW, RDIB, WSCI

Read | Permalink | Email this | Linking Blogs | Comments

…read more
Source: FULL ARTICLE at DailyFinance

24/7 Wall St. Closing Bell — March 19, 2013: Market Closes Mixed Without Solution in Cyprus (JNPR, RIO, CHK, EBAY, EA, FF, SBLK, FDS, WAG, ADBE, CTAS, FTEK, WSM, FDX, GIS, LEN, AFFY, S, HAL, SLB)

By 24/7 Wall St.

Bull and Bear figures

Filed under:

U.S. equity markets opened higher this morning but worries about a resolution to the banking crisis in Cyprus soon took over and pushed shares down. In other parts of Europe, Spain’s bad loan ratio rose to 10.78% in January and eurozone economic sentiment came in far below expectations. German 10-year bond yields fell on a rising dollar. In Asia, China’s central bank will drain 39 billion yuan in liquidity with a short-term repurchase agreement after foreign direct investment fell less than expected in the month. In the U.S., the report on housing starts was somewhat better than last month, with an annualized 917,000 new homes being built (more coverage here). The Cypriot parliament rejected a revised tax proposal on bank deposits (more coverage here), so it’s anyone’s guess what tomorrow may bring.

The U.S. dollar index rose 0.35% today, now at 82.983. The GSCI commodity index is down 0.3% at 650.30, with commodities prices mixed today. WTI crude oil closed down 1.7% today, at $92.16 a barrel. Brent crude trades down 1.8% at $107.50 a barrel. Natural gas is up 2.1% today at about $3.96 per million BTUs. Gold settled up 0.4% today at $1,611.30 an ounce.

The unofficial closing bells put the DJIA up about 4 points to 14,455.90 (0.03%), the NASDAQ fell more than 8 points (-0.26%) to 3,229.10, and the S&P 500 fell -0.24% or nearly 4 points to 1,548.35.

There were a several analyst upgrades and downgrades today, including Juniper Networks Inc. (NYSE: JNPR) cut to ‘sell’ at Goldman Sachs; Rio Tinto plc (NYSE: RIO) cut to ‘sell’ at Goldman Sachs; Chesapeake Energy Corp. (NYSE: CHK) cut to ‘underperform’ at Sterne Agee (more coverage here); eBay Inc. (NASDAQ: EBAY) raised to ‘buy’ with a price target of $56 at Cantor Fitzgerald; and Electronic Arts Inc. (NASDAQ: EA) cut to ‘hold’ at Needham.

Earnings reports since markets closed last night resulted in several price moves today, including these: FutureFuel Corp. (NYSE: FF) is down 9.2% at $12.40; Star Bulk Carriers Corp. (NASDAQ: SBLK) is up 5.7% at $6.50; FactSet Research Systems Inc. (NYSE: FDS) is down 5.6% at $92.52; and Walgreen Co. (NYSE: WAG) is up 5.2% at $44.65 (more coverage here).

Before markets open tomorrow morning we are scheduled to hear from Adobe Systems Inc. (NASDAQ: ADBE), Cintas Corp. (NASDAQ: CTAS), Fuel Tech Inc. (NASDAQ: FTEK), Williams-Sonoma Inc. (NYSE: WSM), FedEx Corp. (NYSE: FDX), General Mills Inc. (NYSE: GIS), and Lennar Corp. (NYSE: LEN).

Some standouts among heavily traded stocks today include:

Affymax Inc. (NASDAQ: AFFY) is down 62.6% at $1.09 after posting a new 52-week low of $1.02 earlier today. The drugmaker fired 75% of its workforce today and will begin exploring “strategic alternatives” including bankruptcy. More coverage here.

Sprint Nextel Corp. (NYSE: S) is up 2.9% at $6.05 after posting a new 52-week high of $6.09 earlier today. The telecom company had no big news today, but led a sector that was up on a down day.

Halliburton Co. (NYSE: HAL) is down 3.4% at $39.36. The oil field …read more
Source: FULL ARTICLE at DailyFinance

Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Fir

By Business Wirevia The Motley Fool

Filed under:

Lawyers Seek to Restore Investors’ Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP

DALLAS–(BUSINESS WIRE)– Deans & Lyons LLP securities lawyers announced potential claims on behalf of shareholders of Affymax (NAS: AFFY) who purchased or acquired stock from December 8, 2011 until February 22, 2013. Concerned AFFY investors with stock losses are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.

“Following a report that the FDA was requiring a recall of the company’s lead drug, due to reports of ‘serious and life-threatening’ allergic reactions, shares of Affymax declined 85%,” said shareholder rights lawyer Hamilton Lindley. “The shareholder lawsuits, filed in the Northern District of California, seek to compensate investors for their losses and require better corporate governance from company management.”

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. AFFY stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Deans & Lyons LLP
Hamilton Lindley, 214-736-7861
Fax: 214-965-8505
Toll Free: 877-819-8033
www.deanslyons.com

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:

The article Lawyers Seek to Restore Investors’ Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} else if (obj.attachEvent){
…read more
Source: FULL ARTICLE at DailyFinance

The Best- And Worst-Performing Biotech Stocks In February

By Matthew Herper, Forbes Staff These are the best and worst-performing medical and biotech stocks in February 2013. We ran a screen of biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations of more than $300 million at the beginning or end of the month. The data come from Interactive Data and Thomson Reuters Fundamentals via FactSet Research Systems. February’s Best-Performing Biotech Stocks Company Ticker 1-month price change% 52-week price change % Recent Market Value ($MIL) Optimer Pharmaceuticals Inc. OPTR 30.6 -28.5 578.0 Questcor Pharmaceuticals Inc. QCOR 27.9 -28.1 1,905.5 Celldex Therapeutics Inc. CLDX 27.6 57.4 590.0 Pharmacyclics Inc. PCYC 26.6 277.2 6,117.9 Taro Pharmaceutical Industries Ltd. TARO 22.3 46.9 2,537.1 February’s Worst-Performing Biotech Stocks Company Ticker 1-month price change% 52-week price change % Recent Market Value ($MIL) OraSure Technologies Inc. OSUR -21.1 -36.6 306.8 Synta Pharmaceuticals Corp. SNTA -23.3 143.0 531.7 Keryx Biopharmaceuticals Inc. KERX -29.2 167.8 462.5 Dynavax Technologies Corp. DVAX -34.0 -11.2 364.6 Affymax Inc. AFFY -85.9 135.4 98.5   …read more
Source: FULL ARTICLE at Forbes Latest